The EVIDENCE 360: RWE, Pricing & Reimbursement Summit Europe focuses on the impact of Real World Evidence (RWE), pricing models, and reimbursement strategies in healthcare, addressing challenges like data analytics, regulatory issues, and personalized medicine in Europe.
Key Topics
- Managing regional disparities in reimbursement policies and the need for harmonization of pricing models across Europe.
- The rise of data analytics tools—how AI, machine learning, and big data are shaping the future of RWE analysis and usage.
- Leveraging patient-centered data and incorporating Patient Reported Outcomes (PRO’s) to better address unmet needs and optimize healthcare access.
- Navigating regulatory challenges surrounding RWE data acceptance, standardization, and quality control in European markets.
- The Future of Personalized Medicine and its Impact on Pricing and Reimbursement
- Understanding how RWE influences HTAs in Europe, with a focus on improving the alignment between pricing, reimbursement decisions, and clinical effectiveness.
